EML4 is currently receiving attention due to its possible fusion with anaplastic lymphoma kinase (ALK) forming pathological EML4-ALK variants associated with lung cancer (Chen et al., 2015; Sabir et al., 2017; Adib et al., 2019). Here, EML4 is linked to lung cancer.